Literature DB >> 8353080

Severe hypocalcaemia after treatment with oral clodronate and aminoglycoside.

J I Mayordomo, F Rivera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8353080     DOI： 10.1093/oxfordjournals.annonc.a058530

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Adverse effects of bisphosphonates. A comparative review.

Authors:  S Adami; N Zamberlan
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.

Authors:  A Mishra; L Wong; J Jonklaas
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

Review 3.  Bisphosphonates and the treatment of bone disease in the elderly.

Authors:  A Johansen; M Stone; F Rawlinson
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

Review 4.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.